Ireland· IE-PA-PA0281/224/002
Ceftazidime 2g Powder for solution for injection or infusion
A ceftazidime product containing ceftazidime, registered in Ireland by Pinewood Laboratories Ltd. The same ATC class is registered in 18 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ceftazidime is registered in 18 of 19 countries.
Countries holding a registration under ATC J01DD02 (ceftazidime), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Ceftazidime · ATC J01DD02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ceftazidime costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ceftazidime · price per daily dose (4 g)
USD · FX 28 Sept 2026
- CH Switzerland$129.98
The record
At a glance
HPRA (Ireland)- Active substance
- Ceftazidime
- Manufacturer
- Pinewood Laboratories Ltd
- Country
- Ireland (IE)
- ATC code
- J01DD02
- ATC class
- Ceftazidime
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0281/224/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
155 interactions on record for ceftazidime.
Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ceftazidime · interactions on record
155 records
- 34 moderate
- 121 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- Amphotericin BA07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ceftazidime in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALTECIMMedochemie Ltd., Limassol
- FinlandCeftazidim ActavisActavis Group PTC ehf
- BelgiumCeftazidim Fresenius Kabi 2000 mgFresenius Kabi
- SpainALFAGEM 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGMedochemie Limited
- United StatesCeftazidimeSagent Pharmaceuticals
- PolandBiotumZakłady Farmaceutyczne POLPHARMA S.A.
- IcelandCeftazidim Fresenius KabiFresenius Kabi AB
- NorwayCeftazidim Fresenius KabiFresenius Kabi Norge AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
- Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Bulgaria · Алфагем, Зидимцеф
- Cyprus · Alfagem, Cezid
- Czechia · Altecim, Ceftazidim Aptapharma
- Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
- Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Estonia · Altecim, Ceftazidime Fresenius Kabi
- Spain · Alfagem, Ceftazidima Kabi
- Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
- United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
- Greece · Alfagem, Ceftaridem
- Croatia · Altecim, Cefaz
- Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
- Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
- Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
- Lithuania · Biotum, Ceftazidime Kabi
- Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
- Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
- Malta · Alfagem, Ceftazidima Fresenius
- Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
- Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Poland · Biotum, Ceftazidim Aptapharma
- Portugal · Alfagem, Ceftazidima Accord
- Romania · Alfagem, Ceftamil
- Sweden · Ceftazidim Hameln, Fortum
- Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
- Slovakia · Ceftazidim Ash, Ceftazidim Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08964a5c-e047-4046-b917-1d1618b15ad7 GET /v1/drugs/08964a5c-e047-4046-b917-1d1618b15ad7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection/infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J01DD",
"J01DD02"
],
"strength": null,
"pa_number": "PA0281/224/002",
"substances": [
"Ceftazidime"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "17/12/2004",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ceftazidime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.